FDA Approved Exoskeleton
FDA has approved Argo Medical Technologies to sale the first Exoskeleton and they are calling it ReWalk. Argo Medical Technologies, or Argo, can now market its products in the U.S. With the aid of crutches, people who are paralyzed from the waist down will be able to put their wheel chairs aside and use the robotic apparatus to walk again. The price for a unit is $69,500.
ReWalk Users in London Courtesy of Argo Medical Technologies
Argo Medical Technologies mission is to fundamentally change the health and life experiences of individuals with spinal cord injuries.
The ReWalk™ is the result of this mission; it is a world-class walking system that will allow paraplegics to bring walking into their daily lives once again. Culminating over a decade of research and development, the ReWalk represents the first truly practical, real world, walking solution for persons with lower limb disabilities.
Argo founder Dr. Amit Goffer was inspired to develop the ReWalk exoskeleton unit because of his own personal story. Dr. Goffer is quadriplegic and he founded Argo in 2001. His goal was to develop a product that would enable persons with spinal cord injuries to walk again. Over the past decade, Argo has grown from a small research and development start-up based in Israel to an international company with headquarters in the US, Germany and Israel.
Argo has been working internationally with leading rehabilitation centers in testing and developing a rehabilitation model of the ReWalk. As a result of these efforts, Argo has been able to develop the ReWalk Personal, the next phase of exoskeleton technology designed exclusively for use in everyday life. Employing Argo’s proprietary technology, the ReWalk Personal is designed for everyday use.
Posted by Michael Kaudze on 07/07 at 09:26 AM